Dow Jones Futures:
Tesla, Leader in Buying Territories
Dow Jones Futures: Tesla, Leader in Buying Territories
When looking at
Dow Jones futures, Tesla is seen to be a leader in purchasing regions. Bitcoin, on the other hand, is rising as Coinbase IPO stalls.
Along with
Dow Jones futures, S&P 500 futures and Nasdaq futures, the stock market race was set to settle this morning after the positive session on Tuesday.
Investors are waiting for JPMorgan and other major banks' earnings earlier today. On the cryptocurrency exchange Coindesk, Bitcoin continues to reach new heights overnight.
According to the transaction in Dow Jones on Tuesday, Johnson & Johnson dropped a little after calling for a break from the administration of the coronavirus vaccine.
But the Nasdaq composite rose sharply with the help of falling treasury yields. Nasdaq 100; It has reached new heights supported by
Apple (AAPL), Amazon.com (AMZN), Microsoft (MSFT), Adobe (ADBE) and specifically Tesla stock.
Apple shares and Amazon rose to the right of the foundations, while MSFT shares were at the edge of a buying territory.
Tesla (TSLA) signaled an early buy along with Adobe stock and vaccine game Maravai LifeSciences (MRVI).
Key Earnings:
JPMorgan Chase (JPM), Goldman Sachs (GS) and Wells Fargo (WFC) reported earnings on Wednesday.
Coinbase (COIN) will go public with Bitcoin at an all-time high.
Coinbase IPO
Coinbase goes public via a direct listing, unlike a traditional initial public offering.
Coinbase, the first cryptocurrency exchange to go public, is the largest US cryptocurrency exchange trading 50 different digital assets. Having made significant profits, Coinbase saw significant growth due to interest in Bitcoin and other digital asset booms.
Coinbase's first quarter revenue of $ 1,8 billion exceeded $ 1,3 billion for the full year of 2020.
Bitcoin price exceeded $ 63,000 for the first time on Tuesday and reached $ 64,000 on Wednesday. This situation has seriously boosted Coinbase as well.
Dow Jones Futures Today
Dow Jones futures rose at fair value. S&P 500 futures rose 0,1 %, while futures on the Nasdaq 100 increased.
J&J Vaccine
The Johnson & Johnson vaccine has gained immense popularity as it only requires a single dose. In addition, many states used the J&J vaccine to reach rural areas, as storage conditions are easier than Pfizer (PFE) and Moderna (MRNA) vaccines.
JNJ shares, on tuesday at morning lows, lost 1,3 % of its value.
BioNTech (BNTX) rose 6,7 %, approaching a point of purchase, while its partner Pfizer' stock rose 0,5% .
Moderna shares rose 7,4 %, just above the 50-day mark.
Close to FDA approval for its vaccine, Novavax (NVAX) jumped 11 %.
AstraZeneca (AZN), which has also been associated with an extremely low clotting risk, dropped 0,5%.
After the closure, Pfizer said it could give the US 10 % more doses than previously accepted by the end of May.
Moderna said his vaccine was 90 % effective six months after the second dose, and an updated version was effective for the South African variant.
Tesla, Aggressive Entry
Tesla shares rose 8,6 % in above-average trading to 762,32. TSLA shares rose above the 50-day line and March highs, one day after this rise above the 10-week line.
It is not ideal for Tesla stocks to move above the falling 50-day line, like some other valuable stocks trying to recover. Still, this is of great importance as it is the first TSLA buy signal for aggressive traders in months.
You may also be interested in: